XML 88 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-based Compensation Expense
12 Months Ended
Dec. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-based Compensation Expense
Share-based Compensation Expense

Total share-based compensation expense for all stock awards consists of the following (in thousands):

 
Years Ended
 
December 30,
2012
 
January 1,
2012
 
January 2,
2011
Cost of product revenue
$
7,575

 
$
6,951

 
$
5,378

Cost of service and other revenue
461

 
695

 
470

Research and development
30,879

 
32,105

 
25,428

Selling, general and administrative
55,409

 
52,341

 
40,369

Share-based compensation expense before taxes
94,324

 
92,092

 
71,645

Related income tax benefits
(30,759
)
 
(32,168
)
 
(25,231
)
Share-based compensation expense, net of taxes
$
63,565

 
$
59,924

 
$
46,414



The assumptions used for the specified reporting periods and the resulting estimates of weighted-average fair value per share of options granted and for stock purchased under the ESPP during those periods are as follows:

 
Years Ended
 
December 30,
2012
 
January 1,
2012
 
January 2,
2011
Stock options granted:
 
 
 
 
 
Risk-free interest rate
0.56 - 0.93%

 
0.85 - 2.23%

 
2.05 - 2.73%

Expected volatility
41 - 48%

 
41 - 53%

 
46 - 48%

Expected term
4.0 - 6.6 years

 
4.7 - 5.5 years

 
6.0 years

Expected dividends

 

 

Weighted average fair value per share
$
15.47

 
$
27.47

 
$
18.82

 
 
 
 
 
 
Stock purchased under the ESPP:
 
 
 
 
 
Risk-free interest rate
0.09 - 0.17%

 
0.16 - 0.30%

 
0.17 - 0.48%

Expected volatility
33 - 64%

 
43 - 48%

 
46 - 48%

Expected term
0.5 - 1.0 year

 
0.5 - 1.0 year

 
0.5 - 1.0 year

Expected dividends

 

 

Weighted average fair value per share
$
16.45

 
$
20.08

 
$
11.10



As of December 30, 2012, approximately $177.8 million of total unrecognized compensation cost related to stock options, restricted stock units, and ESPP shares issued to date is expected to be recognized over a weighted-average period of approximately 2.3 years.